Summer 2024

This issue is sponsored by the Midwest Lipid Association

0
No votes yet

Midwest Chapter of the NLA explores a unique topic in this issue of LipidSpin that impacts all of our clinical decisions: exploring the costs of cardiovascular disease prevention. Every day, clinicians seek to provide the best care for patients, reducing cardiovascular risk, promoting a vital... more

0
No votes yet

Disease prevention can lead to optimal promotion of health and improved quality of life. To achieve this goal, the concept must be emphasized by the clinician and adopted by the patient. Modifiable risk factors such as diet, exercise, smoking, etc. have long been recognized as causing or... more

0
No votes yet

Introduction It is common to hear the saying “it is expensive to eat healthy”, but does it have to be? When it comes to healthy eating, it isn’t only the cost that can be unsettling, but the massive amount of conflicting nutrition information available to interpret. The anxiety surrounding “What... more

0
No votes yet

I am honored to be leading the Midwest Lipid Association this year. I started working for Ohio State 25 years ago and had a variety of teaching duties with medical students, residents, and fellows with a primary emphasis on psychiatry and cardiovascular prevention. I was asked to start a Lipid... more

0
No votes yet

As the physicians employed by a government hospital, we frequently encounter patients facing significant social and financial challenges. This often leads to a sense of isolation within the medical community. At Cook County Health in Chicago, we provide medical care to 50% of the uninsured... more

0
No votes yet

Introduction Atherosclerotic Cardiovascular disease (ASCVD) is the leading cause of death worldwide, and uncontrolled lipids are a major modifiable risk factor for ASCVD.1 Statin therapy remains the cornerstone for ASCVD risk-reduction, yet optimal lipid control remains suboptimal.2 Current... more

0
No votes yet

Case  A 62-year-old woman with a past medical history significant for pre-diabetes, hypertension, hyperlipidemia (HLD), and obesity presented to her primary care physician for a routine six-month follow up. She recently became more proactive about her health given one of her colleagues... more

0
No votes yet

The focus of this article is to provide a guide for clinicians and patients to effectively navigate the healthcare system in general, as well as in terms of specific lipid-related health concerns. Lennert Griese et al. in their 2020 article, “Challenges in Navigating the Health Care System:... more

0
No votes yet

Hello NLA members,  I am honored to serve as the 2024-2025 National Lipid Association President, and present to you the fall installment of LipidSpin, Exploring the Costs of Cardiovascular Disease Prevention. As a busy clinician myself, I look forward to the discussion this edition may... more

0
No votes yet